FDA Approves Hemophilia Drug FEIBA for Bleeding Prophylaxis FDA Approves Hemophilia Drug FEIBA for Bleeding Prophylaxis

Previously marketed for treatment of bleeding in hemophilia, the anti-inhibitor coagulant complex is now available for prophylaxis. FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news